Nanomedicine-Based Neuroprotective Strategies in Patient Specific-iPSC and Personalized Medicine
In recent decades, nanotechnology has attracted major interests in view of drug delivery systems and therapies against diseases, such as cancer, neurodegenerative diseases, and many others. Nanotechnology provides the opportunity for nanoscale particles or molecules (so called “Nanomedicine”) to be...
Main Authors: | Shih-Fan Jang, Wei-Hsiu Liu, Wen-Shin Song, Kuan-Lin Chiang, Hsin-I Ma, Chung-Lan Kao, Ming-Teh Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/15/3/3904 |
Similar Items
-
Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells
by: Ying-Chieh Wu, et al.
Published: (2021-07-01) -
The role of mutations associated with familial neurodegenerative disorders on blood–brain barrier function in an iPSC model
by: Moriah E. Katt, et al.
Published: (2019-07-01) -
The EBiSC iPSC bank for disease studies
by: Rachel Steeg, et al.
Published: (2020-12-01) -
Human iPSC banking: barriers and opportunities
by: Ching-Ying Huang, et al.
Published: (2019-10-01) -
Patient-Specific iPSC-Derived RPE for Modeling of Retinal Diseases
by: Huy V. Nguyen, et al.
Published: (2015-03-01)